Page last updated: 2024-10-27

2,5-dihydroxybenzoic acid and Autoimmune Diseases

2,5-dihydroxybenzoic acid has been researched along with Autoimmune Diseases in 2 studies

2,5-dihydroxybenzoic acid: RN given refers to parent cpd; a oxidative product of saligenin
2,5-dihydroxybenzoic acid : A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions.

Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.

Research Excerpts

ExcerptRelevanceReference
"The aim of the present study was to compare the effect produced by juvenile rheumatoid arthritis (JRA) or rheumatic fever (RF) on the pharmacokinetics of acetyl salicylic acid (ASA) and its metabolites in children with autoimmune diseases (AD)."7.72Comparative pharmacokinetics of acetyl salicylic acid and its metabolites in children suffering from autoimmune diseases. ( Carbajal Rodríguez, L; Flores Pérez, J; Juárez Olguín, H; Lares Asseff, I; Loredo Abdalá, A, 2004)
"The aim of the present study was to compare the effect produced by juvenile rheumatoid arthritis (JRA) or rheumatic fever (RF) on the pharmacokinetics of acetyl salicylic acid (ASA) and its metabolites in children with autoimmune diseases (AD)."3.72Comparative pharmacokinetics of acetyl salicylic acid and its metabolites in children suffering from autoimmune diseases. ( Carbajal Rodríguez, L; Flores Pérez, J; Juárez Olguín, H; Lares Asseff, I; Loredo Abdalá, A, 2004)
" The study illustrates the need for pharmacokinetic data to establish the individual doses of drugs, particularly in conditions that alter nutritional status."1.30Influence of nutritional status on the pharmacokinetics of acetylsalicylic acid and its metabolites in children with autoimmune disease. ( Carbajal-Rodríguez, L; Flores-Pérez, J; Juárez-Olguín, H; Lares-Asseff, I; Loredo-Abdalá, A; Ramírez-Lacayo, M, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Juárez Olguín, H1
Flores Pérez, J1
Lares Asseff, I1
Loredo Abdalá, A1
Carbajal Rodríguez, L1
Lares-Asseff, I1
Flores-Pérez, J1
Juárez-Olguín, H1
Ramírez-Lacayo, M1
Loredo-Abdalá, A1
Carbajal-Rodríguez, L1

Other Studies

2 other studies available for 2,5-dihydroxybenzoic acid and Autoimmune Diseases

ArticleYear
Comparative pharmacokinetics of acetyl salicylic acid and its metabolites in children suffering from autoimmune diseases.
    Biopharmaceutics & drug disposition, 2004, Volume: 25, Issue:1

    Topics: Administration, Oral; Adolescent; Area Under Curve; Arthritis, Juvenile; Aspirin; Autoimmune Disease

2004
Influence of nutritional status on the pharmacokinetics of acetylsalicylic acid and its metabolites in children with autoimmune disease.
    The American journal of clinical nutrition, 1999, Volume: 69, Issue:2

    Topics: Adolescent; Anthropometry; Area Under Curve; Aspirin; Autoimmune Diseases; Biotransformation; Body W

1999